InvestorsHub Logo
Followers 21
Posts 2539
Boards Moderated 0
Alias Born 12/07/2013

Re: lettruthringout post# 325585

Thursday, 02/18/2021 9:44:47 AM

Thursday, February 18, 2021 9:44:47 AM

Post# of 425850

At the beginning of
Amarin’s clinical trial, Amarin hosted a group of experts to solicit their input on the trial design and the
potential effects of EPA. C.A.J.A. 43971, 43974-43977.
Amarin provided those experts with extensive materials on EPA, including a summary of the prior art studies.
The experts expressed the view that, upon administering pure EPA, bad cholesterol “is likely to go up as it
does with virtually all [triglyceride] lowering therapies
in” patients with severe hypertriglyceridemia.
C.A.J.A. 47719-47722.
Those experts turned out to be wrong.



Yet Judge Du says t was obvious !!!

A panel of experts prior to the the trial says it wont work and DU says it was obvious it would work !!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News